Understanding the Rising Pharmacy Costs: Challenges for Employers and Brokers

The landscape of healthcare costs is undergoing a seismic shift, with pharmacy expenses now rising at a rate that outpaces even medical costs. This alarming trend presents a myriad of challenges for employers, particularly those operating self-funded health plans. The confluence of expensive specialty drugs, worsening population health, and an intricate relationship between employers and pharmacy benefit managers (PBMs) has created a perfect storm for rising pharmacy costs. Brokers and employers must understand this evolving dynamic to effectively manage their healthcare expenditures.

Rick Kelly, National Pharmacy Lead and Senior Vice President at Marsh McLennan Agency (MMA), sheds light on the forces driving this acceleration in pharmacy spending. According to Kelly, the drug pipeline is increasingly filled with specialty medications that often come with exorbitant price tags. While these drugs may offer groundbreaking treatments, the costs associated with them pose significant financial burdens for employers. Furthermore, the prevalence of chronic conditions and an aging population only exacerbate this issue, leading to increased demand for high-cost medications.

The Underlying Factors Behind Rising Pharmacy Costs

Several key factors contribute to the rising costs of pharmacy benefits:

• Specialty Drug Prevalence: The growing number of specialty drugs, which can cost thousands of dollars per month, has become a major contributor to overall pharmacy spending.
• Population Health Trends: As the population ages and chronic diseases become more common, the demand for expensive medications continues to increase.
• PBM Profit Models: The traditional spread pricing model used by many PBMs leads to a lack of transparency and can result in inflated costs for employers.
• Manufacturers’ Pricing Strategies: Pharmaceutical companies often segment rebates and fees in ways that obscure the true costs of medications to employers.

The Role of Pharmacy Benefit Managers

Pharmacy Benefit Managers (PBMs) play a crucial role in the healthcare supply chain, acting as intermediaries between drug manufacturers, pharmacies, and employers. However, the manner in which PBMs operate often leads to misalignment with the interests of the employers they serve. The spread pricing model is particularly problematic; it allows PBMs to charge employers one rate while reimbursing pharmacies at a lower rate, pocketing the difference. This lack of transparency can leave employers unaware of the true costs associated with their pharmacy benefits.

Moreover, the way PBMs handle manufacturer rebates has evolved over time. What was once a straightforward pass-through mechanism has now become convoluted, with rebates often divided into marketing and distribution fees. As Kelly points out, employers frequently do not understand the full extent of how PBMs generate revenue, creating a significant knowledge gap that brokers must bridge.

Formulary Design and Its Impact on Costs

Another critical area where employers can better manage pharmacy costs is through understanding formulary design—the list of covered medications that a PBM offers. Employers should not merely focus on rebate percentages or discount rates but rather delve into how a PBM constructs its preferred drug list. For instance, does the PBM prioritize lower-cost biosimilars, or does it lead with more expensive originator drugs? This knowledge is vital, as it can significantly impact overall pharmacy spending.

One class of medications that has garnered considerable attention in recent years is glucagon-like peptide-1 (GLP-1) receptor agonists, known for their effectiveness in weight loss and diabetes management. Despite their potential to improve health outcomes, the costs associated with these drugs can be staggering. For employers covering GLP-1s for weight loss, annual expenses can exceed their entire merit pool for employee raises, prompting many to reconsider how they provide access to these medications.

Cost vs. Benefit: A Delicate Balance

Employers must weigh the immediate costs of covering high-priced medications against the potential long-term benefits of improved employee health. Kelly raises a pertinent question: if employees who benefit from these medications leave the company before the employer realizes the cost savings from improved health, who ultimately reaps the rewards? This dilemma illustrates the complexities that employers face as they strive to balance competitive compensation packages with sustainable healthcare costs.

Strategies for Employers and Brokers

As pharmacy costs continue to escalate, brokers play a pivotal role in helping employers navigate these challenges. Here are some strategies that brokers can leverage:

• Enhancing Transparency: Brokers should ensure that employers understand the financial arrangements with PBMs, including how rebates and fees are structured.
• Negotiating Better Terms: Brokers can advocate for more favorable pricing arrangements with PBMs, emphasizing the importance of aligning the interests of all parties involved.
• Educating Clients: Providing employers with clear information about formulary design and the implications of drug coverage decisions can help them make informed choices.
• Exploring Alternative Funding Models: Employers might consider alternative funding arrangements like health reimbursement arrangements (HRAs) to give employees more control over their healthcare spending.

Emphasizing Employee Communication

Amidst these complexities, clear communication with employees is essential. As employers transition to models that offer foundational coverage combined with flexible HRAs, employees need guidance on how to allocate funds effectively. Brokers should assist employers in crafting communication strategies that empower employees to make informed decisions about their healthcare options.

Key Takeaways

• Pharmacy costs are rising faster than medical costs, posing challenges for employers.
• The role of PBMs is complex, and employers often lack transparency regarding pricing models.
• Understanding formulary design is crucial for managing pharmacy expenses.
• Employers must balance the costs of high-priced medications against potential long-term health benefits.
• Brokers can play a critical role in enhancing transparency, negotiating terms, and educating clients.

Frequently Asked Questions

What are the main drivers of rising pharmacy costs?

Rising pharmacy costs are driven by several factors, including the increasing prevalence of specialty drugs, worsening population health, and the profit models employed by PBMs. As drug manufacturers introduce more expensive medications, employers must grapple with the financial implications, which often exceed their budgeted expectations.

How can employers better manage pharmacy benefits?

Employers can better manage pharmacy benefits by enhancing transparency with PBMs, understanding how formulary design impacts costs, and exploring alternative funding models like HRAs. Additionally, educating employees about their healthcare options and providing clear communication about benefits can lead to more informed decision-making.

What role do brokers play in addressing pharmacy cost challenges?

Brokers play a vital role in advocating for employers by negotiating better terms with PBMs, enhancing transparency in pricing models, and educating clients on the intricacies of pharmacy benefits. By providing strategic guidance, brokers can help employers navigate the complexities of rising pharmacy costs.

Are there any potential long-term benefits to covering high-cost medications?

While covering high-cost medications can lead to improved employee health and productivity, employers must carefully consider the timing of these benefits. If employees leave the company before the employer realizes the cost savings, the financial burden may outweigh the advantages. Thus, a strategic approach is necessary to ensure that immediate costs align with potential long-term benefits.